GGrantIndex
← Leaderboards

David G Harrison

Vanderbilt University Medical Center

$36,205,139
Attributed
$38,169,548
Total exposure
22
Grants
18
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.6M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$74,388,799 · 25

By mechanism

P01$50,362,245 · 13
R01$12,922,582 · 7
T32$5,835,363 · 2
R35$5,262,896 · 1
R13$5,000 · 1
M01$713 · 1

Top collaborators

Others in their field

Top investigators on “Inflammation

Research focus

InflammationHypertensionCellsProductionT-LymphocytePreventReactive Oxygen SpeciesBlood VesselsAffectAngiotensin IiBlood PressureNadph OxidaseCytokineResponseProgramsPlayT-Cell ActivationKidneyLaboratoriesMediatingLeadSodiumSuperoxidesCollaborations

Grant awards (128)

The intersection of immunity and cardiovascular diseases$3,043,800
P01 · FY2025 · HL · contact PI
Administrative Core$507,301
P01 · FY2025 · HL · contact PI
Antigen-Presentation of Isolevuglandin-modified peptides in hypertension, autoimmunity and target-organ damage$507,300
P01 · FY2025 · HL · contact PI
Common Inflammation Pathways between Aging and Hypertension That Weaken Bone$494,062
R01 · FY2025 · AG · contact PI
Mechanisms of Immune Activation in Hypertension$736,486
R35 · FY2024 · HL · contact PI
Common Inflammation Pathways between Aging and Hypertension That Weaken Bone$508,935
R01 · FY2024 · AG · contact PI
Mechanisms of Immune Activation in Hypertension$751,516
R35 · FY2023 · HL · contact PI
Common Inflammation Pathways between Aging and Hypertension That Weaken Bone$514,125
R01 · FY2023 · AG · contact PI
Vanderbilt Hypertension and Blood Pressure Regulation Program$382,647
T32 · FY2023 · HL · contact PI
Mechanisms of Immune Activation in Hypertension$751,658
R35 · FY2022 · HL · contact PI
Common Inflammation Pathways between Aging and Hypertension That Weaken Bone$517,585
R01 · FY2022 · AG · contact PI
Vanderbilt Hypertension and Blood Pressure Regulation Program$414,451
T32 · FY2022 · HL · contact PI
Mechanisms of Immune Activation in Hypertension$751,897
R35 · FY2021 · HL · contact PI
Vanderbilt Hypertension and Blood Pressure Regulation Program$390,642
T32 · FY2021 · HL · contact PI
The Role of Inflammation in Cardiovascular Disease$2,413,071
P01 · FY2020 · HL · contact PI
Mechanisms of Immune Activation in Hypertension$752,131
R35 · FY2020 · HL · contact PI
Mechanisms of T cell Activation in Hypertension$571,206
P01 · FY2020 · HL · contact PI
Vanderbilt Hypertension and Blood Pressure Regulation Program$314,928
T32 · FY2020 · HL · contact PI
ADMINISTRATIVE & BIOSTATICAL CORE$184,139
P01 · FY2020 · HL · contact PI
The Role of Inflammation in Cardiovascular Disease$2,413,071
P01 · FY2019 · HL · contact PI
Mechanisms of Immune Activation in Hypertension$752,131
R35 · FY2019 · HL · contact PI
Mechanisms of T cell Activation in Hypertension$571,206
P01 · FY2019 · HL · contact PI
Vanderbilt Hypertension and Blood Pressure Regulation Program$233,800
T32 · FY2019 · HL · contact PI
ADMINISTRATIVE & BIOSTATICAL CORE$184,139
P01 · FY2019 · HL · contact PI
The Role of Inflammation in Cardiovascular Disease$2,413,071
P01 · FY2018 · HL · contact PI
Mechanisms of Immune Activation in Hypertension$767,077
R35 · FY2018 · HL · contact PI
Mechanisms of T cell Activation in Hypertension$571,206
P01 · FY2018 · HL · contact PI
The Role of Inflammation in Cardiovascular Disease$296,986
P01 · FY2018 · HL · contact PI
ADMINISTRATIVE & BIOSTATICAL CORE$184,139
P01 · FY2018 · HL · contact PI
The Role of Inflammation in Cardiovascular Disease$2,413,071
P01 · FY2017 · HL · contact PI
Mechanisms of T cell Activation in Hypertension$571,206
P01 · FY2017 · HL · contact PI
The Role of The T Cell In The Genesis of Hypertension$395,000
R01 · FY2017 · HL · contact PI
Immunity, Inflammation and Hypertension$395,000
R01 · FY2017 · HL · contact PI
ADMINISTRATIVE & BIOSTATICAL CORE$184,139
P01 · FY2017 · HL · contact PI
The Role of Inflammation in Cardiovascular Disease$2,485,571
P01 · FY2016 · HL · contact PI
Mechanisms of T cell Activation in Hypertension$585,443
P01 · FY2016 · HL · contact PI
The Role of The T Cell In The Genesis of Hypertension$392,500
R01 · FY2016 · HL · contact PI
Immunity, Inflammation and Hypertension$333,273
R01 · FY2016 · HL · contact PI
ADMINISTRATIVE & BIOSTATICAL CORE$188,894
P01 · FY2016 · HL · contact PI
Immunity, Inflammation and Hypertension$56,727
R01 · FY2016 · HL · contact PI
Role of Vascular Oxidative Stress in Obesity$466,926
R01 · FY2015 · HL
The Role of The T Cell In The Genesis of Hypertension$392,500
R01 · FY2015 · HL · contact PI
Immunity, Inflammation and Hypertension$384,150
R01 · FY2015 · HL · contact PI
Therapeutic Modulation of Endothelial Cell Tetrahydrobiopterin$355,210
P01 · FY2015 · GM · contact PI
Role of Vascular Oxidative Stress in Obesity$468,598
R01 · FY2014 · HL
Immunity, Inflammation and Hypertension$409,583
R01 · FY2014 · HL · contact PI
Therapeutic Modulation of Endothelial Cell Tetrahydrobiopterin$350,110
P01 · FY2014 · GM · contact PI
Interactions Between Inflammation, Oxidant Stress and Cardiovascular Disease$1,580,415
P01 · FY2013 · HL · contact PI
Role of Vascular Oxidative Stress in Obesity$459,026
R01 · FY2013 · HL
Immunity, Inflammation and Hypertension$390,000
R01 · FY2013 · HL · contact PI
Roles of oxidation and inflammation in aortic stiffening$367,567
R01 · FY2013 · HL · contact PI
T cell triggering events and hypertension$345,143
P01 · FY2013 · HL · contact PI
Therapeutic Modulation of Endothelial Cell Tetrahydrobiopterin$323,929
P01 · FY2013 · GM · contact PI
The role of the T Cell in the Genesis of Hypertension$294,613
P01 · FY2013 · HL · contact PI
Administrative Core$169,249
P01 · FY2013 · HL · contact PI
Immunity, Inflammation and Hypertension$65,459
R01 · FY2013 · HL · contact PI
Interactions Between Inflammation, Oxidant Stress and Cardiovascular Disease$1,674,579
P01 · FY2012 · HL · contact PI
Role of Vascular Oxidative Stress in Obesity$499,562
R01 · FY2012 · HL
The role of the T Cell in the Genesis of Hypertension$411,200
P01 · FY2012 · HL · contact PI
Roles of oxidation and inflammation in aortic stiffening$386,100
R01 · FY2012 · HL · contact PI
T cell triggering events and hypertension$367,787
P01 · FY2012 · HL · contact PI
Therapeutic Modulation of Endothelial Cell Tetrahydrobiopterin$336,082
P01 · FY2012 · GM · contact PI
Administrative Core$124,334
P01 · FY2012 · HL · contact PI
VASCULATA-2012$5,000
R13 · FY2012 · HL · contact PI
Interactions Between Inflammation, Oxidant Stress and Cardiovascular Disease$1,250,277
P01 · FY2011 · HL · contact PI
Interactions Between Inflammation, Oxidant Stress and Cardiovascular Disease$437,124
P01 · FY2011 · HL · contact PI
Roles of oxidation and inflammation in aortic stiffening$387,500
R01 · FY2011 · HL · contact PI
T cell triggering events and hypertension$367,779
P01 · FY2011 · HL · contact PI
Regulation of Vascular Function by the Endothelium$344,250
R01 · FY2011 · HL · contact PI
Therapeutic Modulation of Endothelial Cell Tetrahydrobiopterin$333,454
P01 · FY2011 · GM · contact PI
The role of the T Cell in the Genesis of Hypertension$329,278
P01 · FY2011 · HL · contact PI
The role of the T Cell in the Genesis of Hypertension$114,340
P01 · FY2011 · HL · contact PI
Administrative Core$108,768
P01 · FY2011 · HL · contact PI
Administrative Core$37,739
P01 · FY2011 · HL · contact PI
Interactions Between Inflammation, Oxidant Stress and Cardiovascular Disease$1,712,866
P01 · FY2010 · HL · contact PI
Research Training in Academic Cardiology$503,320
T32 · FY2010 · HL · contact PI
The role of the T Cell in the Genesis of Hypertension$445,481
P01 · FY2010 · HL · contact PI
Roles of oxidation and inflammation in aortic stiffening$387,500
R01 · FY2010 · HL · contact PI
T cell triggering events and hypertension$366,674
P01 · FY2010 · HL · contact PI
Regulation of Vascular Function by the Endothelium$344,250
R01 · FY2010 · HL · contact PI
Administrative Core$145,680
P01 · FY2010 · HL · contact PI
Interactions Between Inflammation, Oxidant Stress and Cardiovascular Disease$1,745,492
P01 · FY2009 · HL · contact PI
Research Training in Academic Cardiology$499,471
T32 · FY2009 · HL · contact PI
The role of the T Cell in the Genesis of Hypertension$447,418
P01 · FY2009 · HL · contact PI
T cell triggering events and hypertension$366,637
P01 · FY2009 · HL · contact PI
Regulation of Vascular Function by the Endothelium$344,250
R01 · FY2009 · HL · contact PI
Administrative Core$147,230
P01 · FY2009 · HL · contact PI
Research Training in Academic Cardiology$380,746
T32 · FY2008 · HL · contact PI
Regulation of Vascular Function by the Endothelium$344,250
R01 · FY2008 · HL · contact PI
Regulation of eNOS Expression by NfkB, Shear Stress, and Exercise$325,201
P01 · FY2008 · HL · contact PI
Molecular Control of Vascular Function by Oxidant Stress$1,853,718
P01 · FY2007 · HL · contact PI
The Role of Extracellular Superoxide Dismutase in Modulation of Hypertension$483,521
P01 · FY2007 · HL · contact PI
Research Training in Academic Cardiology$475,074
T32 · FY2007 · HL · contact PI
Regulation of Vascular Function by the Endothelium$344,250
R01 · FY2007 · HL · contact PI
Regulation of eNOS Expression by NfkB, Shear Stress, and Exercise$323,547
P01 · FY2007 · HL · contact PI
Molecular Control of Vascular Function by Oxidant Stress$1,856,684
P01 · FY2006 · HL · contact PI
The Role of Extracellular Superoxide Dismutase in Modulation of Hypertension$291,912
P01 · FY2006 · HL · contact PI
Regulation of eNOS Expression by NfkB, Shear Stress, and Exercise$266,224
P01 · FY2006 · HL · contact PI
Regulation of Vascular Function by the Endothelium$259,750
R01 · FY2006 · HL · contact PI
Research Training in Academic Cardiology$193,449
T32 · FY2006 · HL · contact PI
Molecular Control of Vascular Function by Oxidant Stress$1,849,265
P01 · FY2005 · HL
Research Training in Academic Cardiology$439,239
T32 · FY2005 · HL
Post-transcriptional Regulation of NO Synthase$372,377
R01 · FY2005 · HL
The Role of Extracellular Superoxide Dismutase in Modulation of Hypertension$285,260
P01 · FY2005 · HL
Regulation of Vascular Function by the Endothelium$266,000
R01 · FY2005 · HL
Regulation of eNOS Expression by NfkB, Shear Stress, and Exercise$259,653
P01 · FY2005 · HL
Molecular Control of Vascular Function by Oxidant Stress$1,730,657
P01 · FY2004 · HL
Research Training in Academic Cardiology$475,074
T32 · FY2004 · HL
Regulation of Vascular Function by the Endothelium$266,000
R01 · FY2004 · HL
Regulation of eNOS Expression by NfkB, Shear Stress, and Exercise$252,090
P01 · FY2004 · HL
R-haGAL on Progression of Renal Disease in Fabry Disease$713
M01 · FY2004 · RR
Molecular Control of Vascular Function by Oxidant Stress$1,744,319
P01 · FY2003 · HL
RESEARCH TRAINING IN ACADEMIC CARDIOLOGY$272,699
T32 · FY2003 · HL
Regulation of Vascular Function by the Endothelium$266,000
R01 · FY2003 · HL
MOLECULAR CONTROL OF VASCULAR FUNCTION BY OXIDANT STRESS$1,130,586
P01 · FY2002 · HL
Regulation of Vascular Function by the Endothelium$266,000
R01 · FY2002 · HL
RESEARCH TRAINING IN ACADEMIC CARDIOLOGY$203,985
T32 · FY2002 · HL
PHENOTYPIC CONSEQUENCES OF VASCULAR OXIDANT STRESS$173,995
P01 · FY2002 · HL
MOLECULAR CONTROL OF VASCULAR FUNCTION BY OXIDANT STRESS$1,101,454
P01 · FY2001 · HL
RESEARCH TRAINING IN ACADEMIC CARDIOLOGY$337,557
T32 · FY2001 · HL
REGULATION OF VASCULAR FUNCTION BY THE ENDOTHELIUM$221,455
R01 · FY2001 · HL
EXTRACELLULAR SUPEROXIDE DISMUTASE AND ATHEROSCLEROSIS$199,721
R01 · FY2001 · HL
PHENOTYPIC CONSEQUENCES OF VASCULAR OXIDANT STRESS$173,995
P01 · FY2001 · HL
MOLECULAR CONTROL OF VASCULAR FUNCTION BY OXIDANT STRESS$1,073,174
P01 · FY2000 · HL
RESEARCH TRAINING IN ACADEMIC CARDIOLOGY$318,281
T32 · FY2000 · HL
REGULATION OF VASCULAR FUNCTION BY THE ENDOTHELIUM$216,731
R01 · FY2000 · HL
PHENOTYPIC CONSEQUENCES OF VASCULAR OXIDANT STRESS$209,143
P01 · FY2000 · HL
EXTRACELLULAR SUPEROXIDE DISMUTASE AND ATHEROSCLEROSIS$195,620
R01 · FY2000 · HL